Mirati Therapeutics Inc logo

Mirati Therapeutics Inc

$ 77.40 -1.68 (-2.12%) 04:00 PM EST
P/E:
At Loss
P/B:
3.76
Market Cap:
$ 4.19B
Enterprise V:
$ 3.27B
Volume:
723.11K
Avg Vol (2M):
1.10M
Also Trade In:
Volume:
723.11K
Market Cap $:
4.19B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.10M
Enterprise Value $:
3.27B
PB Ratio:
3.76
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Mirati Therapeutics Inc
NAICS : 325412 SIC : 2834
3545 Cray Court, San Diego, CA, USA, 92121
Description
Mirati Therapeutics Inc is a clinical-stage oncology company developing novel therapeutics to address the genetic and immunological promoters of cancer. It operates in a single geographical segment being the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 23.57
Equity-to-Asset 0.87
Debt-to-Equity 0.05
Debt-to-EBITDA -0.08
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 12.88
Distress
Grey
Safe
Beneish M-Score 0.56
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.5
9-Day RSI 51.64
14-Day RSI 55.74
6-1 Month Momentum % -34.84
12-1 Month Momentum % -57.1

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.1
Quick Ratio 10.1
Cash Ratio 9.91

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19.4

Financials (Next Earnings Date:2022-11-08 Est.)

MRTX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:MRTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 78.163
EPS (TTM) ($) -11.85
Beta 0.43
Volatility % 98.35
14-Day RSI 55.74
14-Day ATR ($) 5.200938
20-Day SMA ($) 76.125
12-1 Month Momentum % -57.1
52-Week Range ($) 32.96 - 195.99
Shares Outstanding (Mil) 55.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mirati Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More